Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Leukocyte Adhesion Deficiency Management Market, and What Factors Will Drive It?
The market size for managing leukocyte adhesion deficiency has witnessed considerable growth in recent times. The market, which is projected to grow from $8.07 billion in 2024 to $8.59 billion in 2025, will expand at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period is a result of factors such as improved awareness and education, progress in genetic testing, orphan drug designations, international health policies, patient advocacy groups, and advancements in pediatric healthcare.
The leukocyte adhesion deficiency management market size is expected to see strong growth in the next few years. It will grow to $11.28 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to precision medicine approaches, emergence of novel therapeutics, expanded genetic testing accessibility, patient-centric drug development, advancements in immunomodulatory therapies. Major trends in the forecast period include stem cell transplantation innovations, integration of supportive therapies, telemedicine for remote consultations, collaboration and research networks, integration of biomarker technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13172&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Leukocyte Adhesion Deficiency Management Market?
The increase in incidences of primary immunodeficiency is predicted to fuel the expansion of the leukocyte adhesion deficiency management market. Primary immunodeficiency is a cluster of inherited conditions that compromise the immune system, making individuals prone to infections and sickness due to impaired immunity responses. The management of leukocyte adhesion deficiency enhances our knowledge of immune system disorders and can potentially lead to improved diagnostics and therapeutic interventions for both conditions. For example, in April 2023, Peace Hospital, a multi-specialty hospital in India, stated that data gathered during World Primary Immunodeficiency Awareness Week 2023 indicates that primary immunodeficiency impacts roughly 60 lakh people globally, and 70% to 90% of these individuals have undiagnosed primary immunodeficiency. Hence, the growing occurrences of primary immunodeficiency will boost the leukocyte adhesion deficiency management market.
Which Primary Segments of the Leukocyte Adhesion Deficiency Management Market Are Driving Growth and Industry Transformations?
The leukocyte adhesion deficiency managementmarket covered in this report is segmented –
1) By Treatment: Hematopoietic Stem Cell Transplantation; Recombinant Human Interferon-Gamma Treatment; Prophylactic Immunoglobulin Therapy; Antimicrobial Therapy; Prophylactic Therapy; Fucose Supplementation; Monoclonal Antibodies; Coagulation Factors
2) By Diagnosis: Blood Test; Genetic Testing; Biopsy; Other Types
3) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Hematopoietic Stem Cell Transplantation: Related Donor Transplant; Unrelated Donor Transplant
2) By Recombinant Human Interferon-Gamma Treatment: Standard Dosing; Customized Dosing
3) By Prophylactic Immunoglobulin Therapy: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
4) By Antimicrobial Therapy: Antibiotics; Antifungal Treatments
5) By Prophylactic Therapy: Vaccination Strategies; Infection Prevention Protocols
6) By Fucose Supplementation: Oral Supplements; Intravenous Supplements
7) By Monoclonal Antibodies: Specific Target Monoclonal Antibodies; Combination Therapy Monoclonal Antibodies
8) By Coagulation Factors: Factor Replacement Therapies; Novel Coagulation Agents
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13172&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Leukocyte Adhesion Deficiency Management Market?# Market?
North America was the largest region in the leukocyte adhesion deficiency management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukocyte adhesion deficiency management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Most Significant Market Trends in the Leukocyte Adhesion Deficiency Management Market?
Primary firms in the leukocyte adhesion deficiency management market, such as Rocket Pharmaceuticals, are making strides in gene therapy technology, particularly lentiviral vector-based methods to cater to more precise treatments and to boost patient outcomes. This pioneering technology aims to deliver corrective genes straight into cells to possibly mend immune function. For instance, Rocket Pharmaceuticals, an American biotech corporation, introduced kresladi (marnetegragene autotemcel) in February 2024 for the remedy of severe leukocyte adhesion deficiency-I (LAD-I). This led to a 100% survival rate after 12 months in a Phase 1/2 study, dramatically reducing infections and alleviating symptoms. Kresladi presents an innovative solution in the LAD management market, tackling integral unattended needs.
View the full report here:
What Parameters Are Used to Define the Leukocyte Adhesion Deficiency Management Market?
Leukocyte adhesion deficiency (LAD) is a rare genetic disorder affecting the immune system’s ability to fight infections. It is characterized by a defect in the adhesion (stickiness) of white blood cells, specifically neutrophils, essential for the body’s defense against bacteria and fungi. Management of leukocyte adhesion deficiency typically involves a multidisciplinary approach and focuses on preventing and treating infections and addressing the underlying immune system dysfunction.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13172
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model